Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer

Identifying a molecular profile to predict the risk of recurrence in high‐intermediate risk endometrial cancer

Abstract Background Patients with high‐intermediate risk endometrial cancer (H‐IR EMCA) have an elevated risk of recurrence compared to low‐risk counterparts. Many H‐IR EMCA patients are treated with radiation or chemotherapy, but their overall survival is not significantly impacted by treatment. Th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rebecca C. Arend, Carly B. Scalise, Jhalak Dholakia, Maahum Z. Kamal, Haley B. Thigpen, David Crossman, Warner K. Huh, Charles A. Leath III
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
biomarker
endometrial cancer
high‐intermediate risk
mutations
recurrence
survival
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/88d7d8534aaa441ab511558f98f4d091
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/88d7d8534aaa441ab511558f98f4d091

Ejemplares similares